Efficacy of etanercept in psoriatic patients previously treated with systemic therapy or phototherapy - 25/08/11
Doi : 10.1016/j.jaad.2003.10.512
Bruce E Strober, MD, PhD a, Paul Yamauchi, MD, PhD b, Neil Korman, MD, PhD c, Seth Stevens, MD d
a New York University School of Medicine, New York, NY, United States USA
b Clinical Research Specialists, Santa Monica, CA, United States USA
c Case Western Reserve University, Cleveland, OH, United States USA
d Amgen Inc., Thousand Oaks, CA, United States USA
 | Sponsored by Immunex Corporation, a wholly owned subsidiary of Amgen Inc., and by Wyeth. |
| Dr Strober is a speaker for Amgen. Dr Yamauchi does not have any financial conflicts of interest. Dr Korman received a grant from Amgen to support this clinical trial. Dr Stevens is an employee of Amgen. |
© 2004
Publié par Elsevier Masson SAS.
Vol 50 - N° 3S
P. P147 - mars 2004 Retour au numéro
Article précédent
- Successful treatment of psoriasis and psoriatic arthritis with etanercept and methotrexate in a patient newly unresponsive to infliximab
- Bruce E Strober
- Comparative pharmacokinetics of etanercept in patients with psoriasis or rheumatoid arthritis
- Ivan Nestorov, Todd DeVries, Ralph Zitnik
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?